Hot Features
Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
AlloVir Inc is a late clinical-stage cell therapy company. It is developing allogeneic T cell therapies to treat and prevent devastating viral diseases. The firm's pipeline includes ALVR106, ALVR109, ALVR108, and others. The company's product candidate, Viralym-M, is a multi-VST therapy targeting fi... AlloVir Inc is a late clinical-stage cell therapy company. It is developing allogeneic T cell therapies to treat and prevent devastating viral diseases. The firm's pipeline includes ALVR106, ALVR109, ALVR108, and others. The company's product candidate, Viralym-M, is a multi-VST therapy targeting five viruses namely BK virus, cytomegalovirus, adenovirus, Epstein-Barr virus, and human herpesvirus 6. Mehr anzeigen
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.0367 | -6.69952537422 | 0.5478 | 0.56 | 0.4758 | 334517 | 0.50930137 | CS |
| 4 | -0.113901 | -18.2241308414 | 0.625001 | 0.7495 | 0.4758 | 410585 | 0.56485845 | CS |
| 12 | -0.2289 | -30.9324324324 | 0.74 | 1.05 | 0.4758 | 338546 | 0.72324322 | CS |
| 26 | -0.233 | -31.3129955651 | 0.7441 | 1.05 | 0.4758 | 320006 | 0.73428114 | CS |
| 52 | -1.8289 | -78.1581196581 | 2.34 | 2.485 | 0.4758 | 784527 | 0.78018012 | CS |
| 156 | -19.6989 | -97.4710539337 | 20.21 | 20.625 | 0.4758 | 696846 | 3.47975393 | CS |
| 260 | -0.0551 | -9.73154362416 | 0.5662 | 48.96 | 0.4758 | 565183 | 7.34980761 | CS |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
